Trademark Overview
On Thursday, October 31, 2024, a trademark application was filed for CEREVANCE with the United States Patent and Trademark Office. The USPTO has given the CEREVANCE trademark a serial number of 98830357. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, July 25, 2025. This trademark is owned by Cerevance, Inc.. The CEREVANCE trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, and Computer & Software Services & Scientific Services categories with the following description:
Downloadable software for use in facilitating medical and pharmacological research; downloadable software applications for use in facilitating medical and pharmacological research; downloadable software for use in facilitating drug discovery research; downloadable software applications for use in facilitating drug discovery research; downloadable software for use in facilitating the delivery of drugs; downloadable software applications for use in facilitating the delivery of drugs
Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceuticals for the treatment of obesity; pharmaceuticals for the treatment of central nervous system diseases and disorders; drug delivery agents in the form of injectable solutions, powders, tablets, capsules, coatings for tablets and edible wafers that provide controlled release of the active ingredients for a wide variety of pharmaceuticals
Medical and pharmacological research services; drug discovery services; pharmaceutical drug development services; scientific investigations and research for medical purposes; research and development of vaccines and medicines; analysis of human tissues for scientific and medical research purposes; design and development of medical diagnostic apparatus and software applications; providing online non-downloadable software for use in medical and pharmacological research; software as a service (SaaS) for use in medical and pharmacological research; providing online non-downloadable software for use in drug discovery; Software as a service (SaaS) for use in drug discovery; providing online non-downloadable software for use in facilitating the delivery of drugs; Software as a service (SaaS) for use in facilitating the delivery of drugs; consultancy, information and advisory services relating to all the afore-mentioned services